Compare AbCellera Biologics Inc (ABCL) vs Allstate Corp (ALL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Allstate Corp — how do they compare? AbCellera Biologics Inc trades at $8.98 (market cap $2.99B), while Allstate Corp trades at $262 (market cap $66.31B). The key difference: Allstate Corp is far larger — about 22.2× AbCellera Biologics Inc's market cap, and Allstate Corp pays a 1.65% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | ALL | |
|---|---|---|
Market Cap | $2.99B | $66.31B |
Sector | Health | Financials |
52-Week High | $9.76 | $275.11 |
52-Week Low | $2.78 | $190.00 |
Enterprise Value | $2.58B | $74.96B |
Dividend Yield | — | 1.65% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Allstate Corp
On the basis of premium sales, Allstate is one of the largest U.S. property and casualty insurers. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 agencies.
Read more on ALL →
